Prevention of Complications of Thalassemia
预防地中海贫血并发症
基本信息
- 批准号:7907533
- 负责人:
- 金额:$ 15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-30 至 2012-09-29
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
ABSTRACT:
The model New York Presbyterian Hospital-Weill Medical College of Cornell University (NYPH-WMC)
Thalassemia Center is the largest program in the New York area for the care of over 100 thalassemia
patients and their families which aims to promote health and improve the quality of life of thalassemia
patients. Specifically, the NYPH-WMC aims to provide comprehensive medical, psychosocial and
genetic services. A multidisciplinary on-site diagnostic, treatment and support team comprised of the
director, a pediatric hematologist, pediatric and adult hepatologists, endocrinologists, cardiologists,
radiologist, biochemist, geneticist, social worker and psychologist, genetic counselor, nurse practitioner,
and study and outreach coordinators delivers comprehensive preventive services and participates in
clinical and basic research to advance the understanding of thalassemia and improve management.
Regular transfusions are administered at bi-monthly visits, monthly chemistries, quarterly evaluations and
annual assessments including hepatic, endocrine and cardiac evaluations, hearing and eye exams are
performed with surveillance and monitoring of clinical outcomes. Consultative comprehensive healthcare
services are provided to the local and regional community of thalassemia patients and healthcare
providers. Culturally competent screening, genetic counseling and prenatal diagnosis are also provided
on-site and in outreach programs to identify those who can benefit from education, treatment and
prevention services as well as to assess the needs of the underserved. Collaborations with local and
national consumer organizations are maintained with the Thalassemia Action Group (TAG), the Cooley's
Anemia Foundation (CAF) and local healthcare providers at smaller non-federally funded regional
institutions which care for fewer thalassemia patients. Annual patient/parent educational conferences are
conducted and annual medical update symposiums are held for healthcare providers. Comprehensive
healthcare services are directed at attaining and measuring specific outcomes to prevent and reduce
complications of transfusional iron overload implementing the CDC's Thalassemia Universal Data
Collection Surveillance Program for the investigation of seroconversion suspected, blood borne agents
and possible bacterial contamination along with other data collection and surveillance efforts. NARRATIVE:
The overall purpose of the NYPH-WMC Thalassemia Center's partnership with the CDC is aimed at
promoting the health and improving the quality of life of patients with thalassemia by providing a
prevention evaluation network to monitor blood safety and the delivery of comprehensive healthcare
services to monitor and prevent the complications of transfusional iron overload, and to conduct research
to enhance prevention and implement preventive strategies that will advocate and contribute to the
development of public health policies.
抽象的:
模型纽约长老会医院-康奈尔大学威尔医学院 (NYPH-WMC)
地中海贫血中心是纽约地区最大的项目,为 100 多名地中海贫血患者提供护理
旨在促进地中海贫血患者及其家人的健康并提高其生活质量
患者。具体而言,NYPH-WMC 旨在提供全面的医疗、心理社会和
遗传服务。多学科现场诊断、治疗和支持团队,包括
主任、儿科血液学家、儿科和成人肝病学家、内分泌学家、心脏病学家、
放射科医生、生物化学家、遗传学家、社会工作者和心理学家、遗传咨询师、执业护士、
研究和外展协调员提供全面的预防服务并参与
临床和基础研究,以增进对地中海贫血的了解并改善管理。
定期输血是在每两个月访视、每月化学检查、每季度评估和
年度评估包括肝脏、内分泌和心脏评估、听力和眼科检查
通过监测和监测临床结果进行。咨询式综合医疗保健
为当地和地区的地中海贫血患者和医疗保健社区提供服务
提供商。还提供文化能力筛查、遗传咨询和产前诊断
现场和外展项目以确定那些可以从教育、治疗和
预防服务以及评估服务不足者的需求。与当地和
国家消费者组织由地中海贫血行动小组 (TAG)、Cooley's
贫血基金会 (CAF) 和小型非联邦资助地区的当地医疗保健提供者
照顾较少地中海贫血患者的机构。年度患者/家长教育会议是
为医疗保健提供者举办年度医疗更新研讨会。综合的
医疗保健服务旨在实现和衡量特定结果,以预防和减少
实施 CDC 地中海贫血通用数据的输血铁超负荷并发症
用于调查可疑血清转化、血源性病原体的收集监测计划
以及可能的细菌污染以及其他数据收集和监测工作。叙述:
NYPH-WMC 地中海贫血中心与 CDC 合作的总体目的是
通过提供地中海贫血患者的健康和生活质量
预防评估网络,监测血液安全并提供综合医疗保健
监测和预防输血铁超负荷并发症并进行研究的服务
加强预防并实施预防战略,以倡导和促进
制定公共卫生政策。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PATRICIA J GIARDINA其他文献
PATRICIA J GIARDINA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PATRICIA J GIARDINA', 18)}}的其他基金
THALASSEMIA CLINICAL RESEARCH NETWORK CROSS-SECTIONAL STUDY OF OSTEOPOROSIS
地中海贫血临床研究网络骨质疏松症的横断面研究
- 批准号:
7200353 - 财政年份:2005
- 资助金额:
$ 15万 - 项目类别:
相似国自然基金
基于超声影像智能分析技术在评估伴发妊娠期并发症胎儿肺成熟度中的应用
- 批准号:82302196
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
中性粒细胞胞外陷阱在HIV眼部并发症中的作用机制研究
- 批准号:82301262
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
防治肺炎及其并发症的靶向MyD88抑制剂的设计、合成及药理作用研究
- 批准号:
- 批准年份:2022
- 资助金额:51 万元
- 项目类别:面上项目
经导管三尖瓣置换并发症的生物力学机理研究
- 批准号:
- 批准年份:2022
- 资助金额:55 万元
- 项目类别:面上项目
血小板-单核细胞聚集体在ECMO期间血栓并发症中的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Macrophage Functional Response in Hemolytic Complications
溶血并发症中的巨噬细胞功能反应
- 批准号:
10647754 - 财政年份:2020
- 资助金额:
$ 15万 - 项目类别:
Macrophage Functional Response in Hemolytic Complications
溶血并发症中的巨噬细胞功能反应
- 批准号:
10220130 - 财政年份:2020
- 资助金额:
$ 15万 - 项目类别:
Macrophage Functional Response in Hemolytic Complications
溶血并发症中的巨噬细胞功能反应
- 批准号:
10456799 - 财政年份:2020
- 资助金额:
$ 15万 - 项目类别:
Hydroxyurea to Prevent the Central Nervous System Complications of Sickle Cell Disease in Children
羟基脲预防儿童镰状细胞病中枢神经系统并发症
- 批准号:
9810412 - 财政年份:2019
- 资助金额:
$ 15万 - 项目类别:
Hydroxyurea to Prevent CNS Complications of Sickle Cell Disease in Children
羟基脲预防儿童镰状细胞病中枢神经系统并发症
- 批准号:
8865963 - 财政年份:2014
- 资助金额:
$ 15万 - 项目类别: